Analyst Call of the Year: Collins Stewart on Encysive (ENCY) Feb 20, 2008 10:49AM

Normally, Wall Street analysts get beat up in the media for their bad calls. So today we wanted to highlight an outstanding call by an analyst.

The stock: Encysive Pharmaceuticals Inc. (Nasdaq: ENCY).
The analyst: Andrew Fein at Collins Stewart

Yesterday, Fein ...